Merck opens $120m China factory
April 19, 2013Manufacturing and Production, Sales and Marketing China, Merck
Merck is to open a new manufacturing facility in Hangzhou, two decades after the company built its first plant in …
Takeda rapped over quality control failure in Japan
April 19, 2013Manufacturing and Production GMP, OPMA, Takeda
Takeda Pharmaceutical has been penalised by its local trade organisation over the quality failings that led to the recall of …
Sanofi earmarks $75m for Vietnamese plant
April 19, 2013Manufacturing and Production Sanofi, vietnam
Sanofi has broken ground on a new manufacturing facility in Ho Chi Minh City, Vietnam, as part of its push …
GSK faces £2.6 billion fine
April 19, 2013Sales and Marketing GSK, Seroxat, paroxetine
GlaxoSmithKline could be fined £2.6 billion after the Office of Fair Trading (OFT) alleged it paid generics firms to slow …
Digital ad monitoring for UK pharma market launched
April 19, 2013Medical Communications ebiquity
Ebiquity has launched a new service to monitor and benchmark advertising spend and creative for the UK healthcare market. The …
Venaxis appoints former Pfizer executive to Board of directors
April 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams
Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.
£3.5 million for health charities
April 18, 2013Sales and Marketing NHS, UK
A raft of voluntary of charities and community groups are to share £3.5 million in the next financial year as …
Covance opens expanded Singapore lab
April 18, 2013Research and Development Covance
Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …
Lilly increases Alzheimer’s R&D
April 18, 2013Research and Development, Sales and Marketing Alzheimer's, lilly
Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …
Oxford Cancer Biomarkers signs discovery deal with AstraZeneca
April 18, 2013Research and Development AstraZeneca, Oxford Cancer Biomarkers
AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …
Teva-Handok names chief executive
April 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing teva-handok
Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …
Lilly Phase III diabetes boost
April 17, 2013Research and Development, Sales and Marketing diabetes, dulaglutide, lilly
Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …
Dragon’s Den entrepreneur expands into healthcare
April 17, 2013Medical Communications, Research and Development, Sales and Marketing Dragon's den, ab prime advantage, james caan
James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …
Zeno Group hires Rachel Vrettos to lead UK healthcare practice
April 17, 2013Medical Communications, Sales and Marketing Red Door, zeno group
PR agency Zeno Group has confirmed the appointment of Rachel Vrettos as director, Healthcare for its UK operations. Vrettos has …
Mobilising for action in consumer healthcare
April 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A.T. Kearney, healthcare products, marketing
A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals – and …
OHE: drugs spend to rise
April 16, 2013Medical Communications, Sales and Marketing ABPI, OHE
UK medicines expenditure is set to grow between 3.1% and 4.1% by 2015, according to a study which the researchers …
New president and chief executive for Aeterna Zentaris
April 16, 2013Manufacturing and Production, Research and Development, Sales and Marketing aeterna zentaris
Aeterna Zentaris has announced that David Dodd has been appointed as its president and chief executive, succeeding Juergen Engel. Dodd …
Celgene appoints new Haematology head
April 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, browne
Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …
ANI poised to take over BioSante
April 15, 2013Sales and Marketing ANI, biosante
US firms BioSante Pharmaceuticals and ANI Pharmaceuticals have tweaked the terms of the merger they announced last year, and which …
Big pharma appointments to PhRMA Board
April 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA
Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
